Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to 0.22%.

  • Catalyst Pharmaceuticals' Return on Invested Capital rose 300.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.26% for FY2024, which is 1100.0% up from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Return on Invested Capital stood at 0.22%, which was up 300.0% from 0.23% recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Return on Invested Capital registered a high of 0.41% during Q1 2021, and its lowest value of 0.09% during Q2 2024.
  • In the last 5 years, Catalyst Pharmaceuticals' Return on Invested Capital had a median value of 0.22% in 2025 and averaged 0.23%.
  • In the last 5 years, Catalyst Pharmaceuticals' Return on Invested Capital plummeted by -3100bps in 2021 and then surged by 1400bps in 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.19% in 2021, then surged by 46bps to 0.28% in 2022, then tumbled by -48bps to 0.15% in 2023, then soared by 43bps to 0.21% in 2024, then increased by 4bps to 0.22% in 2025.
  • Its Return on Invested Capital stands at 0.22% for Q3 2025, versus 0.23% for Q2 2025 and 0.23% for Q1 2025.